Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
entecavir (baraclude) (1 trial)
epsilonpa-44 (2 trials)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
Trials (3 total)
Trial APIs (2 total)